These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 10952233)

  • 1. ALP isoenzyme separation in type 1 Gaucher disease.
    Ciana G; Tamaro G; Martini C; Ceschel S; Cuttini M; Bembi B
    Clin Chem Lab Med; 2000 May; 38(5):479-80. PubMed ID: 10952233
    [No Abstract]   [Full Text] [Related]  

  • 2. Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns.
    Van Hoof VO; De Broe ME
    Crit Rev Clin Lab Sci; 1994; 31(3):197-293. PubMed ID: 7818774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for enzyme replacement therapy in Gaucher disease.
    Brady RO; Barranger JA; Furbish FS; Stowens DW; Ginns EI
    Prog Clin Biol Res; 1982; 95():669-80. PubMed ID: 7122643
    [No Abstract]   [Full Text] [Related]  

  • 4. A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweight.
    Ucar SK; Coker M; Argin M; Akman S; Kara S; Simsek DG; Darcan S
    Mol Genet Metab; 2009 Jan; 96(1):50-1. PubMed ID: 19006678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassay for the steroid-induced isoenzyme of alkaline phosphatase in the dog.
    Wellman ML; Hoffmann WE; Dorner JL; Mock RE
    Am J Vet Res; 1982 Jul; 43(7):1200-3. PubMed ID: 7103201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of enzyme therapy in a patient with Gaucher disease type III.
    Bosman DK; Hollak CE; Aerts JM; Bakker HD
    J Inherit Metab Dis; 1996; 19(5):703-4. PubMed ID: 8892032
    [No Abstract]   [Full Text] [Related]  

  • 7. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Eur J Biochem; 1981 Apr; 115(3):455-61. PubMed ID: 6786882
    [No Abstract]   [Full Text] [Related]  

  • 8. Liposomes in Gaucher type I disease: use in enzyme therapy and the creation of an animal model.
    Gregoriadis G; Weereratne H; Blair H; Bull GM
    Prog Clin Biol Res; 1982; 95():681-701. PubMed ID: 6812092
    [No Abstract]   [Full Text] [Related]  

  • 9. Properties of alkaline phosphatase in the gingival crevicular fluid.
    Kina JR; Yoshida N; Goseki M; Sasaki S; Ishikawa I
    Bull Tokyo Med Dent Univ; 1995 Jun; 42(2):57-65. PubMed ID: 7796488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternate origin for the placental isoenzyme of alkaline phosphatase.
    Griffiths J
    Arch Pathol Lab Med; 1992 Oct; 116(10):1019-24. PubMed ID: 1417440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological outcome of a patient with Gaucher disease type III treated by enzymatic replacement therapy.
    Dobbelaere D; Sukno S; Defoort-Dhellemmes S; Lamblin MD; Largillière C
    J Inherit Metab Dis; 1998 Feb; 21(1):74-6. PubMed ID: 9501273
    [No Abstract]   [Full Text] [Related]  

  • 12. Alkaline phosphatases in tissues and sera of cats.
    Everett RM; Duncan JR; Prasse KW
    Am J Vet Res; 1977 Oct; 38(10):1533-8. PubMed ID: 931135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gaucher's disease and enzyme replacement therapy].
    Cornu F
    Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease.
    Elstein D; Cohn GM; Wang N; Djordjevic M; Brutaru C; Zimran A
    Blood Cells Mol Dis; 2011 Jan; 46(1):119-23. PubMed ID: 20727796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In brief: Velaglucerase (Vpriv) for Gaucher's disease.
    Med Lett Drugs Ther; 2010 May; 52(1337):36. PubMed ID: 20431522
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy.
    de Fost M; van Noesel CJ; Aerts JM; Maas M; Pöll RG; Hollak CE
    Haematologica; 2008 Jul; 93(7):1119-20. PubMed ID: 18519519
    [No Abstract]   [Full Text] [Related]  

  • 17. The acid phosphatase isoenzymes in normal and pathological sera and in tissue homogenates.
    Rozenszajn L; Epstein Y; Shoham D; Arber I
    J Lab Clin Med; 1968 Nov; 72(5):786-93. PubMed ID: 5697388
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isoenzyme profile of alkaline phosphatase in patients with pancreatitis].
    Parra S; Climent C; De la Peña C; Martínez P
    Rev Esp Enferm Dig; 1992 Apr; 81(4):267-9. PubMed ID: 1599767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Shift of placental alkaline phosphatase isoenzymes in the course of pregnancy].
    Nozawa S; Arai H; Jeng C; Itakura M; Ohta H; Suzuki K; Tamura S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1145-54. PubMed ID: 6210329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-glucosidase isozymes and the enzymatic defect in Gaucher disease.
    Patrick AD
    Prog Clin Biol Res; 1982; 95():287-308. PubMed ID: 6812075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.